Dr Izanne Roos
Senior Research Fellow in Multiple Sclerosis
Department of Medicine
164 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.
DOI: 10.1136/jnnp-2026-3386942026
Journal article
Causal effects of multiple sclerosis therapies in left-truncated registry data
DOI: 10.1177/135245852614599432026
Journal article
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study
DOI: 10.1177/135245852614606582026
Journal article
Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis
DOI: 10.1093/brain/awag0472026
Research grants (ARC, NHMRC, MRFF)
Biomarkers of Multiple Sclerosis Disease Progression and Treatment Response
2025
Research grants (ARC, NHMRC, MRFF)
Evidence Based Use of High-Efficacy Therapies in Multiple Sclerosis
2022
Research Grant
Personalised Therapy to Prevent Disability in Aggressive Multiple Sclerosis
RECENT SCHOLARLY WORKS
2026
Journal article
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.
DOI: 10.1136/jnnp-2026-3390592026
Journal article
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.
DOI: 10.1093/brain/awag2522026
Journal article
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study
DOI: 10.1007/s40263-026-01287-82026
Journal article
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability
DOI: 10.1212/WNL.00000000002180562026
Journal article
Predicting disease progression in multiple sclerosis with clinically accessible information and technology
DOI: 10.1007/s00415-026-13802-42026
Journal article
Performance of the 2024 McDonald diagnostic criteria for multiple sclerosis
DOI: 10.1177/13524585261421816
RECENT PROJECTS
2026
Research grants (other domestic)
Biomarkers of Multiple Sclerosis Disease Progression and Treatment Response
2026
Research grants (other domestic)
Do Anti-Cd20 Therapies Benefit Non-Active Progressive MS? A Causal Inference Analysis Using Observational Data